Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry

JACC. Cardiovascular Interventions
Jason B LindseyEVENT Registry Investigators

Abstract

Our aim was to examine the prognostic importance of hemorrhagic and ischemic complications after percutaneous coronary intervention (PCI) in unselected patients. In randomized trials of PCI, major bleeding and periprocedural myocardial infarction (pMI) have been associated with increased mortality. Whether similar associations exist among un-selected PCI patients is unknown. We used data from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry-a multicenter registry of unselected patients undergoing PCI-to examine the association between both in-hospital bleeding and pMI and 1-year mortality. Cardiac enzyme levels were assessed in all patients, and pMI was defined as a peak creatine kinase-MB value >or=3x the upper limit of normal. Post-PCI bleeding was classified by Thrombolysis In Myocardial Infarction criteria. After excluding patients with elevated pre-PCI creatine kinase-MB values and ST-segment elevation myocardial infarction at presentation (n = 1,626), a total of 5,961 patients were available for evaluation. Rates of post-PCI bleeding and pMI were 3.0% and 7.1%, respectively; 1-year all-cause mortality was 2.8%. After multivariable adjustment, both post-PCI bleeding (adjusted hazard ratio [HR]: 3....Continue Reading

References

Feb 12, 1998·Annals of Internal Medicine·L I Iezzoni
Aug 15, 1998·The New England Journal of Medicine·UNKNOWN Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigato
Oct 18, 2003·Journal of the American College of Cardiology·John P A IoannidisDemosthenes G Katritsis
Oct 8, 2005·American Heart Journal·Amit SegevUNKNOWN Canadian Acute Coronary Syndromes Registries Investigators
Oct 29, 2005·The American Journal of Cardiology·Sunil V RaoRobert A Harrington
Aug 16, 2006·Circulation·John W EikelboomSalim Yusuf
Nov 25, 2006·The New England Journal of Medicine·Gregg W StoneUNKNOWN ACUITY Investigators
Oct 24, 2007·Journal of the American College of Cardiology·Harold L DauermanDavid J Cohen
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Mar 18, 2008·Journal of Interventional Cardiology·James FittsUNKNOWN Northern New England Cardiovascular Study Group
May 24, 2008·The New England Journal of Medicine·Gregg W StoneUNKNOWN HORIZONS-AMI Trial Investigators
Aug 16, 2008·The New England Journal of Medicine·Adnan KastratiUNKNOWN ISAR-REACT 3 Trial Investigators
Mar 7, 2009·Blood·Nathan Fowler, Anas Younes
Dec 25, 2009·Circulation. Cardiovascular Interventions·Lakshmi VenkitachalamUNKNOWN Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries

❮ Previous
Next ❯

Citations

Aug 17, 2010·European Heart Journal·Demosthenes G KatritsisJohn P A Ioannidis
May 9, 2012·The American Journal of Cardiology·Ronald P CaputoJohn J Lopez
Nov 26, 2010·International Journal of Cardiology·Taishi YonetsuMitsuaki Isobe
Dec 9, 2015·Journal of Interventional Cardiology·Mirko D ČolićIgor B Mrdović
Nov 24, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Lisa M FlemingDonald E Cutlip
Nov 24, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Kenneth TandjungClemens von Birgelen
May 5, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Stéphane RinfretSamer Mansour
Mar 21, 2016·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Sherezade KhambattaUNKNOWN Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Investigators
Jun 2, 2010·Journal of the American College of Cardiology·Jeffrey Brinker
Jun 14, 2014·The American Journal of Cardiology·Razi Khan, Hung Q Ly
Dec 17, 2011·American Heart Journal·Eric L EisensteinKevin J Anstrom
Jun 9, 2016·Journal of cardiology·Yohei NumasawaKeiichi Fukuda
Nov 28, 2012·Nature Reviews. Cardiology·Robert A ByrneAdnan Kastrati
Jan 27, 2016·Circulation·Laxmi S MehtaUNKNOWN American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Card
Jan 17, 2019·Journal of the American Heart Association·Tetsuro Tsujimoto, Hiroshi Kajio
Jun 16, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Spyridon DeftereosChristodoulos Stefanadis
Aug 26, 2020·Circulation. Cardiovascular Interventions·Hironori HaraPatrick W Serruys
Jul 1, 2016·Cardiovascular Drugs and Therapy·Carlo BriguoriRaffaele De Caterina
Oct 8, 2020·European Heart Journal. Acute Cardiovascular Care·Christian DworeckElmir Omerovic
Apr 13, 2021·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Raffaele PiccoloPeter Jüni
Sep 28, 2021·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Adam C SalisburyJohn A Spertus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved